- Home
- RNXT vs KITT Comparison
RNXT vs KITT Comparison
Compare RNXT & KITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- KITT
- Stock Information
- Founded
- RNXT 2012
- KITT 2014
- Country
- RNXT United States
- KITT United States
- Employees
- RNXT N/A
- KITT N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- KITT Industrial Machinery/Components
- Sector
- RNXT Health Care
- KITT Industrials
- Exchange
- RNXT Nasdaq
- KITT Nasdaq
- Market Cap
- RNXT 44.6M
- KITT 38.8M
- IPO Year
- RNXT 2021
- KITT N/A
- Fundamental
- Price
- RNXT $1.32
- KITT $0.99
- Analyst Decision
- RNXT Strong Buy
- KITT
- Analyst Count
- RNXT 2
- KITT 0
- Target Price
- RNXT $7.25
- KITT N/A
- AVG Volume (30 Days)
- RNXT 150.2K
- KITT 1.1M
- Earning Date
- RNXT 08-14-2025
- KITT 08-12-2025
- Dividend Yield
- RNXT N/A
- KITT N/A
- EPS Growth
- RNXT N/A
- KITT N/A
- EPS
- RNXT N/A
- KITT N/A
- Revenue
- RNXT $240,000.00
- KITT $1,508,374.00
- Revenue This Year
- RNXT $3,104.65
- KITT $2,936.06
- Revenue Next Year
- RNXT $301.89
- KITT N/A
- P/E Ratio
- RNXT N/A
- KITT N/A
- Revenue Growth
- RNXT N/A
- KITT N/A
- 52 Week Low
- RNXT $0.75
- KITT $0.82
- 52 Week High
- RNXT $1.69
- KITT $6.13
- Technical
- Relative Strength Index (RSI)
- RNXT 50.28
- KITT 51.99
- Support Level
- RNXT $1.28
- KITT $0.95
- Resistance Level
- RNXT $1.40
- KITT $1.09
- Average True Range (ATR)
- RNXT 0.07
- KITT 0.06
- MACD
- RNXT -0.01
- KITT 0.01
- Stochastic Oscillator
- RNXT 40.74
- KITT 52.29
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About KITT Nauticus Robotics Inc.
Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.